BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)
BCRX did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.
Shishin's live daily signals are published each morning on the rankings board.
BCRX did not make Shishin's board on 2026-07-14: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company.
Is BCRX a Shishin signal?
On 2026-07-14, BCRX is not in Shishin's board. Not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a recommendation.
What is BCRX's Shishin momentum score?
As of 2026-07-14, BCRX's composite momentum score is 25/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.
Why didn't BCRX make the board?
Not in a strong uptrend (60-day return under 30%, or below its 50-day average). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.